About David Rubin
Form D filings for Strata Oncology in 2024 list David Rubin as director.
David Rubin first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name David Rubin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Rubin works with at each company, as listed on that company's latest Form D.
Strata Oncology, Inc. · Form D, Nov 22, 2024
MM
Matthew Martin
Chief Financial Officer
DR
Daniel Rhodes
Executive officer and director
KF
Keith Flaherty
Director
Christopher O'Donnell
Director
JW
Jeffrey Williams
Executive officer and director
JP
James Pavlik
Director
JG
Jan Garfinkle
Director